Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-25T21:44:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a phase II clinical trial for urothelial cancer, while adding new identifiers and collaborators related to the study.
    Difference
    48%
    Check dated 2025-04-18T15:30:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    68 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-19T15:48:23.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-12T09:18:19.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-05T06:01:47.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-21T20:43:22.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.